Research report: Response predictors and clonal evolution during thalidomide therapy in myelodysplastic neoplasms with increased blasts
A retrospective study in Annals of Hematology found thalidomide effective in 52% of evaluable patients with high-risk myelodysplastic neoplasms, with ...
